Mark Cuban: The Biggest Problem Lies with Insurance Brokers
Investor Mark Cuban pointed out that the biggest issue in the U.S. healthcare system is not pricing or insurance coverage itself, but rather the deep entrenchment of hospitals with large insurance companies. These companies underpay, delay payments, frequently deny claims, and consume a significant portion of revenue on revenue cycle management (RCM) consulting fees. More critically, in most commercial insurance, the actual payer is the employer, not the insurance entity itself.
He emphasized that about 60% of employee insurance is provided by self-insured employers, with insurance companies merely acting as high-cost intermediaries. Most hospitals do not fully understand whether each insurance contract is profitable or not, and they are reluctant to withdraw for fear of losing patient flow. At the same time, hospitals use inflated pricing through "charge masters" to bill uninsured, self-paying, or partially covered patients exorbitantly, further crushing personal finances.
English industry observations and policy discussions also indicate a complex web of interests among self-insured employers, PBMs, and insurance entities, leading to distorted price signals. A "cost transparency + direct procurement" model that directly connects hospitals and employers has begun piloting in some employee benefit designs.
Source: Public Information
ABAB AI Insight
This structure is essentially not about "high medical costs," but rather about a "misplaced trading structure." Between the supply and demand sides of healthcare services, insurance, PBMs, and multi-layered administrative bodies have been inserted, resulting in significant markups and information decay between cash flow and actual costs. Hospitals are forced to become "high-cost suppliers," while insurers and employers are pushed to become "high-risk purchasers," with the intermediaries being the actual beneficiaries.
A core logic pointed out by Cuban is that hospitals could bypass insurance companies and directly contract with employers at an affordable total price below the current insurance markup, while eliminating the charge master system, shifting risk from vulnerable patients to the more stable capital side of employers and insurance pools. This is economically feasible, but due to institutional inertia, contract stickiness, and organizational fears, the vast majority of systems prefer to maintain the distorted status quo.
In the longer term, this is highly similar to the financialization trend of "structured products": the originally simple relationship of "enterprise-hospital-employee" has been packaged into complex financial instruments of "insurance plans + pharmaceutical management + financial repackaging," making it difficult for each participant to see the real costs while still having to pay for the entire structure. This structure amplifies systemic vulnerabilities during crises, and only when self-insured employers, hospitals, and regulators truly connect "cost visualization" and "direct signing pathways" can the current pricing distortion be reversed.